Literature DB >> 26807248

Evaluation of prognostic scoring systems for bone metastases using single-center data.

Hirofumi Shimada1, Takao Setoguchi2, Shunsuke Nakamura1, Masahiro Yokouchi1, Yasuhiro Ishidou3, Hiroyuki Tominaga1, Ichiro Kawamura1, Satoshi Nagano1, Setsuro Komiya1.   

Abstract

Recent progress in cancer treatment has improved patient survival, but has increased the number of patients with metastatic bone tumors. Data were collected from all bone metastasis patients at Kagoshima University, where almost all patients with metastatic bone tumors who reside in Kagoshima province are treated surgically. The scoring systems used in bone metastasis patients were then evaluated to identify those most suitable for our patients. Clinical data were collected from 145 patients with bone metastases. The patients were assigned prognostic scores based on four scoring systems, namely those described by the Ratasvuori, Mizumoto, Tokuhashi and Katagiri groups. Statistical examinations were performed to assess patient distribution regarding prognostic factors and the four data sets reported in the literature. The patient distributions for all prognostic factors were significantly different between the Scandinavian Sarcoma Group (SSG) and Kagoshima data. The distributions of patients for 3 of 5 and for 5 of 7 prognostic factors were statistically different between the Kagoshima data and the Katagiri and Tokuhashi data, respectively. Additionally, the distribution of patients in each scoring group was statistically different between the Kagoshima data and the Katagiri, Tokuhashi and Mizumoto data. The predictions of prognosis were significantly different between the results of each group and ours. The Tokuhashi scoring system detected the highest survival at 6 months (88.8%) in the Kagoshima data. Patients with a life expectancy of >6 months benefited from tumor excision and reconstruction. These findings suggest that the Tokuhashi scoring system is the most suitable for identifying patients who should be assessed for curative surgical intervention. SSG scoring, however, was suitable for identifying patients expected to survive for <6 months (91.3%). Prior to selecting a scoring system to predict prognosis, it is important to determine which scoring system is the most appropriate, based on each hospital's particular characteristics.

Entities:  

Keywords:  metastatic bone tumor; performance status; prognosis; prognostic factor; scoring

Year:  2015        PMID: 26807248      PMCID: PMC4665315          DOI: 10.3892/mco.2015.637

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  9 in total

1.  A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiromi Matsuzaki; Hiroshi Oda; Masashi Oshima; Junnosuke Ryu
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-01       Impact factor: 3.468

2.  The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I.

Authors:  H L Frankel; D O Hancock; G Hyslop; J Melzak; L S Michaelis; G H Ungar; J D Vernon; J J Walsh
Journal:  Paraplegia       Date:  1969-11

3.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

Review 4.  Skeletal metastases - the role of the orthopaedic and spinal surgeon.

Authors:  Nicholas Eastley; Martyn Newey; Robert U Ashford
Journal:  Surg Oncol       Date:  2012-05-02       Impact factor: 3.279

5.  Prognostic factors and a scoring system for patients with skeletal metastasis.

Authors:  H Katagiri; M Takahashi; K Wakai; H Sugiura; T Kataoka; K Nakanishi
Journal:  J Bone Joint Surg Br       Date:  2005-05

6.  Metastatic bone tumors: Analysis of factors affecting prognosis and efficacy of CT and 18F-FDG PET-CT in identifying primary lesions.

Authors:  Hirofumi Shimada; Takao Setoguchi; Masahiro Yokouchi; Hiromi Sasaki; Yasuhiro Ishidou; Ichiro Kawamura; Masahiko Abematsu; Satoshi Nagano; Setsuro Komiya
Journal:  Mol Clin Oncol       Date:  2014-06-23

7.  Prognostic factors and a scoring system for survival after radiotherapy for metastases to the spinal column: a review of 544 patients at Shizuoka Cancer Center Hospital.

Authors:  Masashi Mizumoto; Hideyuki Harada; Hirofumi Asakura; Takayuki Hashimoto; Kazuhisa Furutani; Haruko Hashii; Tatsuya Takagi; Hirohisa Katagiri; Mitsuru Takahashi; Tetsuo Nishimura
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 8.  Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis.

Authors:  Maire Ratasvuori; Rikard Wedin; Johnny Keller; Markus Nottrott; Olga Zaikova; Peter Bergh; Anders Kalen; Johan Nilsson; Halldor Jonsson; Minna Laitinen
Journal:  Surg Oncol       Date:  2013-04-04       Impact factor: 3.279

9.  Perioperative morbidity and mortality after reconstruction for metastatic tumors of the proximal femur and acetabulum.

Authors:  Robert H Quinn; Jessica Drenga
Journal:  J Arthroplasty       Date:  2006-02       Impact factor: 4.757

  9 in total
  3 in total

1.  Skeletal Metastasis-an Epidemiological Study.

Authors:  Balaji Zacharia; Dhiyaneswaran Subramaniam; Jerin Joy
Journal:  Indian J Surg Oncol       Date:  2017-09-28

2.  Factors Affecting Life Expectancy After Bone Metastasis in Adults - Results of a 5-year Prospective Study.

Authors:  Balaji Zacharia; Jerin Joy; Dhiyaneswaran Subramaniam; Puneeth Katapadi Pai
Journal:  Indian J Surg Oncol       Date:  2021-08-30

3.  Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.

Authors:  Charles Meares; Alexander Badran; David Dewar
Journal:  J Bone Oncol       Date:  2019-02-13       Impact factor: 4.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.